Article
A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients
11 Mar 2008
Abstract excerpt
Both genetic variants and messenger RNA (mRNA) expression of DNA repair and tumor suppressor genes have been investigated as molecular markers for therapy outcome. However, the phenotypic impact of genetic variants often remained unclear, thus the rationale of their use in risk prediction may be limited. We therefore analyzed genetic variants together with anthropometric and lifestyle factors to see how these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
